[ <font color="red">Antazoline_2</font> <font color="red">/_2</font> <font color="red">tetryzoline_2</font> <font color="red">eyedrops_2</font> in comparison with <font color="red">levocabastine_2</font> <font color="red">eyedrops_2</font> in acute allergic conjunctivitis ] . 
<br>
<br> BACKGROUND Allergic conjunctivitis is one of the most frequent allergic diseases of the anterior eye segment . 
<br> METHODS This multicentre , clinical trial was an investigation to compare the antiallergic efficacy , local tolerance and safety of <font color="red">Antazolin_2</font> <font color="red">/_2</font> <font color="red">Tetryzolin_2</font> <font color="red">eye_2</font> <font color="red">drops_2</font> and <font color="red">Levocabastine_2</font> <font color="red">eye_2</font> <font color="red">drops_2</font> <font color="red">._2</font> 69 patients were treated over a 2 weeks course of therapy . The subjective and objective ocular symptoms were documented over the treatment period . 
<br> RESULTS Both eye drops reduced subjective and objective ocular symptoms effective . The difference between the treatments ( p = 0.0395 ) was the faster onset of action of <font color="red">Antazolin_2</font> <font color="red">/_2</font> <font color="red">Tetryzolin_2</font> 30 minutes after administration of the first drop of trial medication . 
<br> CONCLUSION A fast and effective onset of action is of high clinical relevance . Therefore the benefits of using <font color="red">Antazolin_2</font> <font color="red">/_2</font> <font color="red">Tetryzolin_2</font> <font color="red">eye_2</font> <font color="red">drops_2</font> was clearly outweigh .